logo
logo

Prenosis Announces Investment From Pace Healthcare Capital, Bringing Total Funding To Over $20 Million

Mar 09, 2022•over 3 years ago
Chicago

Description

Prenosis, Inc., a precision medicine company, today announced a venture investment from PACE Healthcare Capital, an early-stage investment firm committed to improving health outcomes. This investment brings total funding in the company to over $20 million, including partnerships with Foxconn, Roche Diagnostics, the Defense Threat Reduction Agency, and others.

Company Information

Company

Prenosis

Location

Chicago, Illinois, United States

About

Prenosis is a health tech innovator devoted to ushering in a new era of precision diagnostics in acute care using artificial intelligence. Its ImmunixTM precision diagnostics platform leverages machine learning algorithms trained on deep biological data and broad clinical data designed to capture and illuminate the complex health states of patients more holistically. Its proprietary NOSISTM dataset is one of the largest and fastest-growing hybrid biomarker-clinical datasets for sepsis care. The Sepsis ImmunoScoreTM diagnostic on the ImmunixTM platform has the potential to save thousands of lives and billions of dollars in healthcare spending annually. The Sepsis ImmunoScoreTM is not yet approved for commercial use in the United States.

FundzWatch™ Score

72
Medium Activity

Buyer Intent Analysis

Get personalized insights on buying likelihood